LABIO
LABIO is a private federation of ~17 independent medical biology laboratories in the Bouches-du-Rhône region of France, affiliated with the LBI cooperative network. It delivers reimbursed diagnostic analyses, multiplex PCR, fertility services, and digital results via the KIRO platform.
- Company typePrivate
- Founded2005
- HeadquartersPlan-de-cuques, France
- Headcount51–100
- GTM typeB2C
- OfferingServices
What LABIO does
LABIO (legal name: Laboratoire Indépendant pour Analyses Médicales) is a private federation of independent medical biology laboratories operating across the Bouches-du-Rhône department in southern France, headquartered at 4 avenue du 8 Mai, 13090 Aix-en-Provence. Founded circa 2005 and affiliated with the LBI (Les Biologistes Indépendants) cooperative — France's largest independent medical biology network with ~600 sites and over €800M in consolidated revenue — LABIO operates approximately 17 laboratory sites spanning Marseille (multiple neighborhoods including 5 Avenues, Saint Mitre, Jeanne d'Arc, Saint Marcel, 3 Lucs), Aix-en-Provence, Plan de Cuques, Saint Rémy de Provence, Maussane les Alpilles, Tarascon, Cuges les Pins, La Fare les Oliviers, Eguilles, Puyricard, and Mimet. The organization is staffed by approximately 13 named biologists (physicians, pharmacists, and accredited specialists) supported by technicians, nurses, and administrative staff, and falls within the 51–100 employee band.
LABIO's service portfolio spans routine medical analyses (blood, urine, and biological fluids), bacteriological and mycological sampling, molecular biology diagnostics (multiplex PCR for COVID-19/influenza/RSV, arbovirus screening for Dengue/Zika/Chikungunya), sexually transmitted infection screening, pregnancy monitoring, and health check-ups available without prescription. A specialized PMA (Medically Assisted Reproduction) laboratory, co-located at Centre Hospitalier du Pays d'Aix, delivers IUI, IVF, ICSI, IMSI, embryo vitrification, and sperm cryopreservation. Differentiated delivery channels include a home-sampling service (IDE LAB PAD), Doctolib booking integration for specialized examinations, and two proprietary digital platforms: KIRO (medical-device-grade patient-facing results portal) and LEO (physician-facing results portal).
Revenue is generated primarily through reimbursement from the French Sécurité Sociale for prescribed analyses, supplemented by patient out-of-pocket payments for non-prescribed or specialized tests (e.g., Lipoprotein(a) testing at €26). As part of LBI Coopérative, LABIO participates in pooled procurement that has made LBI France's largest private purchasing center in medical biology. Go-to-market is direct-to-consumer via walk-in laboratory locations combined with physician-referred volumes and digital booking; the company has no app, no public API, and no app-store listing. The operating footprint is exclusively French, restricted to Bouches-du-Rhône, with no international expansion signals.
LABIO firmographics
Firmographics- Name
- LABIO
- Legal name
- Laboratoire Indépendant pour Analyses Médicales
- Website
- https://labio.fr
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- LABIO is a private federation of ~17 independent medical biology laboratories in the Bouches-du-Rhône region of France, affiliated with the LBI cooperative network. It delivers reimbursed diagnostic analyses, multiplex PCR, fertility services, and digital results via the KIRO platform.
- Ownership category
- akta.pro rank
LABIO industry classification
Industry- Product category
- Medical Diagnostic Laboratory Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)
- akta.pro secondary industries
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)
Keywords
Where LABIO is headquartered
LocationHeadquarters
- HQ city
- Plan-de-cuques
- HQ country
- France
- HQ region
- Europe
Offices12 records
Markets served
LABIO business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Medical Biology Analyses: Laboratory medical analysis services for blood, urine, and other biological samples. Revenue generated through reimbursements from French social security (Sécurité Sociale) for prescribed tests, with patient co-payments for non-prescribed or specialized tests. The LBI network operates as a cooperative becoming the largest private purchasing center in French medical biology.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | Standard medical analyses with social security reimbursement |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
LABIO product offering
Product offeringCore offering
LABIO operates a network of independent medical biology laboratories in the Bouches-du-Rhône region of France, providing medical analyses on blood, urine, and other biological samples for patients and healthcare professionals. Services span routine and specialized diagnostics (including multiplex PCR for respiratory pathogens, STI screening, arbovirus screening, and pregnancy monitoring), assisted reproduction (PMA) testing, home blood draw services, and digital result delivery through the KIRO and LEO platforms.
Product overview
LABIO is a federation of independent medical biology laboratories operating in the Bouches-du-Rhône region of France, affiliated with the LBI (Les Biologistes Indépendants) network. The core offering consists of a network of laboratory sites providing medical analysis services including blood tests, urine tests, and biological fluid examinations. The product portfolio includes routine and specialized testing, with specialized modules for COVID-19/respiratory multiplex testing, arbovirus screening (Dengue, Zika, Chikungunya), STI screening, pregnancy monitoring, and a dedicated Medical Assisted Reproduction (PMA) laboratory. Digital services include online result retrieval via the KIRO platform, home blood draw services, and Doctolib appointment booking. The company operates multiple laboratory sites across the region including Aix-en-Provence, Marseille, and surrounding areas.
Differentiator
Problem solved
Functional benefit
Products and services
- Medical Analyses and Biological Testing Core laboratory services including blood tests, urine tests, bacteriological and mycological sampling, PCR testing, and diagnostic screening for patients with or without physician prescriptions. Services are available across 15+ laboratory sites in Bouches-du-Rhône.
- LABIO PMA - Medical Assisted Reproduction Laboratory Specialized laboratory at Centre Hospitalier du Pays d'Aix offering the full range of medically assisted reproduction techniques including intrauterine insemination (IUI), IVF, ICSI, IMSI, embryo vitrification, and sperm cryopreservation, along with diagnostic semen analysis, sperm fragmentation testing, and micronutrition assessments for couples and individuals undergoing fertility treatment.
- Home Blood Draw Service (PAD) At-home blood collection service for patients unable to travel to laboratory facilities due to medical conditions, coordinated through the IDE LAB PAD system with appointments bookable 48-72 hours in advance.
- COVID-19 and Respiratory Multiplex Testing PCR testing using multiplex technology that simultaneously detects COVID-19, influenza, and bronchiolitis (VRS) from a single nasal swab sample, enabling rapid differential diagnosis of respiratory infections.
- Arbovirus Screening Molecular biology (PCR) screening for Dengue, Zika, and Chikungunya viruses, with samples collected at all laboratory sites and results available within 24 business hours.
- Health Check-ups Without Prescription Routine health screening packages available without a doctor's prescription, including fatigue assessments, metabolic panels, and general wellness check-ups for patients seeking self-directed health monitoring.
- IST Screening (STI Screening) Sexually transmitted infection screening services available without a doctor's prescription, including testing for bacterial, viral, and parasitic infections.
- Pregnancy Monitoring Prenatal testing services including B-HCG hormone testing, pregnancy monitoring panels, and related diagnostic examinations for pregnancy follow-up care.
Quantifiable outcome
- Results available same day for most samples collected before 10am
- +1 more outcomes
Companies that use LABIO
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
LABIO technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature4 records
LABIO partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- LBI - Les Biologistes IndépendantscoreLABIO is a federation member of the LBI network, the largest independent medical biology laboratory network in France. LBI represents approximately 600 laboratory sites with over 800 million euros in consolidated revenue. LBI Coopérative became the largest private purchasing center in French medical biology.
- AFEM (Aide aux Familles et Entraide Médicale)minorLABIO has been committed to solidarity for 15 years with AFEM, providing moral and financial support each year to 3 orphans of physicians through scholarships for housing, registration fees, travel and international exchanges.
- ASSAMIminorASSAMI is an association and endowment fund working for 4 theaters in the metropolitan area: Gymnase and Bernardines in Marseille, Grand Théâtre de Provence and Jeu de Paume in Aix-en-Provence. Their philanthropic mission brings live performances to disadvantaged audiences in nursing homes, hospitals, and detention centers.
- Atelier de la Langue FrançaiseminorThe Atelier de la Langue Française promotes access to culture and its sharing. Speech workshops are organized in secondary schools, and the eloquence competition created 10 years ago has national impact and has expanded to French-speaking Africa since 2019.
- Fondation VasarelyminorLABIO supports the Vasarely Foundation and Mécènes du Sud association, engaged with contemporary artists.
- Mécènes du SudminorMécènes du Sud was created in 2003 to stimulate contemporary artistic creation through two collective business co-productions.
- Cercle des Nageurs de MarseilleminorLABIO supports sports and physical well-being through the endowment fund of Cercle des Nageurs de Marseille which finances actions of general interest.
- DoctolibcoreDoctolib is used as the appointment booking platform for specialized laboratory appointments including vaginal sampling, bacteriological tests, fertility consultations, and other specialized examinations.
- KIROcoreKIRO is the digital platform used by LABIO for patients to access their laboratory test results online. KIRO provides visual and interactive result presentation to improve patient comprehension and healthcare experience.
- LEOcoreLEO is the digital platform used by LABIO for healthcare professionals and physicians to access and consult patient laboratory results.
Scale indicators2 records
Recent moves10 records
Expansion highlights5 records
LABIO competitors and assessment
Company assessmentDirect peers
- Synlab: One of Europe's largest medical diagnostics service providers with a major French footprint in clinical biology. Synlab competes head-to-head with LABIO in routine patient diagnostics and operates a similar site-network + central lab model across Bouches-du-Rhône and broader PACA.
- Inovie: Leading independent French medical biology laboratory network with hundreds of patient-facing sites. Inovie directly competes with LABIO for patient referrals, physician relationships, and prescribers in southern France; comparable scope of routine and specialty testing.
- Biogroup: Major French medical biology laboratory group operating extensive patient-facing site networks with central labs. Directly comparable to LABIO in business model (independent network of labs serving patients and prescribers) and geographic overlap in southern France.
- Cerba Healthcare: European reference and specialty clinical diagnostics laboratory group with significant French operations. Comparable to LABIO on routine clinical chemistry and specialty diagnostics (infectious disease, fertility), with additional reference lab reach serving hospital and physician networks.
- Unilabs: European clinical laboratory operator with substantial French site presence offering routine and specialty testing to patients and physicians. Unilabs directly competes with LABIO on walk-in diagnostics, multiplex infectious disease testing, and physician-driven referrals in PACA.
- Laborizon Santé: French network of medical biology laboratories offering routine and specialty testing to patients and prescribers. Comparable to LABIO on regional laboratory network model, NABM-reimbursed routine testing, and digital result delivery.
Broad incumbents
- Eurofins: Global testing services group with a French clinical diagnostics footprint (clinical chemistry, microbiological, molecular) serving hospitals and physicians. Comparable on testing capability and digital platforms but offers a much broader portfolio beyond LABIO's pure medical biology focus.
Regional players
- Dynabio: French independent medical biology laboratory network with a south-of-France footprint. Comparable to LABIO in business model (independent laboratory network serving patients and prescribers) and testing scope, with regional overlap in southern France.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
LABIO social profiles
Digital presenceLABIO financial estimates
Financial estimateRevenue estimate
Valuation estimate
LABIO leadership team
Management profileNumber of profiles
Profiles13 records
LABIO subsidiaries and ownership
Company hierarchySubsidiaries17 records
LABIO funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LABIO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LABIO
What does LABIO do?
LABIO operates a network of independent medical biology laboratories in the Bouches-du-Rhône region of France, providing medical analyses on blood, urine, and other biological samples for patients and healthcare professionals. Services span routine and specialized diagnostics (including multiplex PCR for respiratory pathogens, STI screening, arbovirus screening, and pregnancy monitoring), assisted reproduction (PMA) testing, home blood draw services, and digital result delivery through the KIRO and LEO platforms.
Is LABIO a public or private company?
LABIO is a private company. It is classified as management employee owned and is currently operating.
When was LABIO founded?
LABIO was founded in 2005. It employs 51 to 100 people.
Where is LABIO based?
LABIO is headquartered in Plan-de-cuques, France, in the Europe region.
How does LABIO make money?
One revenue line is on record: medical Biology Analyses.
Who are LABIO's main competitors?
Direct peers on record are Synlab, Inovie, Biogroup, Cerba Healthcare, Unilabs and Laborizon Santé. Eurofins is listed as a broad incumbent. Dynabio is listed as a regional player.
Does LABIO have an API?
No public API is recorded for LABIO.
What industry is LABIO in?
LABIO's product category is Medical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories, with a secondary code of HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 621511 and its SIC code is 8071.